# Varenicline for Smoking Reduction in Veterans Not Ready To Quit

> **NCT06966362** · PHASE4 · NOT_YET_RECRUITING · sponsor: **VA Office of Research and Development** · enrollment: 400 (estimated)

## Conditions studied

- Veterans
- Tobacco Use Disorder
- Cigarette Smoking
- Tobacco Dependence

## Interventions

- **DRUG:** Motivation-Phase Varenicline
- **DRUG:** Motivation-Phase Nicotine Mini-Lozenge
- **DRUG:** Cessation-Phase Combination Nicotine Replacement Therapy (NRT)
- **DRUG:** Cessation-Phase Varenicline
- **BEHAVIORAL:** Motivation-Phase Counseling
- **BEHAVIORAL:** Cessation-Phase Counseling

## Key facts

- **NCT ID:** NCT06966362
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2030-06-28
- **Final completion:** 2030-06-28
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06966362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06966362, "Varenicline for Smoking Reduction in Veterans Not Ready To Quit". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06966362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*